Also Macquarie
ResMed Inc. (RMD AU)Taking a breatherKey points RMD’s 2Q19 result was below our forecasts, with revised cost guidanceahead of expectations. Americas growth remains robust, but with a moderation in RoW devicesgrowth anticipated over the balance of FY19. We see medium-longer term opportunities from SaaS acquisitions, but nearterm risks for the core sleep business. Retain an Underperform rating.
Steady Decline, page-17
Add RWC (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$5.87 |
Change
-0.005(0.09%) |
Mkt cap ! $4.641B | |||
| Open | High | Low | Value | Volume |
| $5.93 | $5.93 | $5.86 | $1.930M | 327.1K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 34 | 15831 | $5.86 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $5.87 | 7306 | 23 |
View Market Depth
| Last trade - 12.24pm 01/10/2024 (20 minute delay) ? |
| RWC (ASX) Chart |